Ligand Pharmaceuticals (LGND) Prepaid Assets (2010 - 2026)

Ligand Pharmaceuticals has disclosed Prepaid Assets across 17 years of filings, most recently posting $5.8 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $5.8 million, down 56.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (down 56.38% YoY), and the FY2025 annual result was $5.8 million, down 34.31% from the prior year.
• Prepaid Assets came in at $5.8 million for Q1 2026 at Ligand Pharmaceuticals, roughly flat from $5.8 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $19.7 million in Q3 2024 to a low of $2.1 million in Q3 2023.
• The 5-year median for Prepaid Assets is $5.8 million (2026), against an average of $6.8 million.
• Across the five-year window, Prepaid Assets sank 80.49% in 2023 and soared 841.39% in 2024, its largest moves.
• Ligand Pharmaceuticals' Prepaid Assets stood at $2.3 million in 2022, then gained by 17.2% to $2.7 million in 2023, then soared by 231.43% to $8.8 million in 2024, then slumped by 34.31% to $5.8 million in 2025, then climbed by 0.17% to $5.8 million in 2026.
• The last three Prepaid Assets figures came in at $5.8 million (Q1 2026), $5.8 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.